Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma

MLA

Shu-Hsuan Liu, et al. “Systematic Identification of Clinically Relevant MiRNAs for Potential MiRNA-Based Therapy in Lung Adenocarcinoma.” Molecular Therapy: Nucleic Acids, vol. 25, no. 1–10, Sept. 2021, pp. 1–10. EBSCOhost, https://doi.org/10.1016/j.omtn.2021.04.020.

APA

Shu-Hsuan Liu, Kai-Wen Hsu, Yo-Liang Lai, Yu-Feng Lin, Fang-Hsin Chen, Pei-Hwa Peng, Li-Jie Lin, Heng-Hsiung Wu, Chia-Yang Li, Shu-Chi Wang, Min-Zu Wu, Yuh-Pyng Sher, & Wei-Chung Cheng. (2021). Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma. Molecular Therapy: Nucleic Acids, 25(1–10), 1–10. https://doi.org/10.1016/j.omtn.2021.04.020

Chicago

Shu-Hsuan Liu, Kai-Wen Hsu, Yo-Liang Lai, Yu-Feng Lin, Fang-Hsin Chen, Pei-Hwa Peng, Li-Jie Lin, et al. 2021. “Systematic Identification of Clinically Relevant MiRNAs for Potential MiRNA-Based Therapy in Lung Adenocarcinoma.” Molecular Therapy: Nucleic Acids 25 (1–10): 1–10. doi:10.1016/j.omtn.2021.04.020.